2019
DOI: 10.1016/j.scitotenv.2018.10.219
|View full text |Cite
|
Sign up to set email alerts
|

Reducing aquatic micropollutants – Increasing the focus on input prevention and integrated emission management

Abstract: Pharmaceuticals and many other chemicals are an important basis for nearly all sectors including for example, food and agriculture, medicine, plastics, electronics, transport, communication, and many other products used nowadays. This comes along with a tremendous chemicalization of the globe, including ubiquitous presence of products of chemical and pharmaceutical industries in the aquatic environment. Use of these products will increase with population growth and living standard as will the need for clean wa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
39
0
2

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 94 publications
(48 citation statements)
references
References 140 publications
0
39
0
2
Order By: Relevance
“…Anthropogenic pollutants, which include pharmaceuticals such as lipid regulators, anticonvulsants and nonsteroidal antiinflammatory drugs, have been found in aquatic environments worldwide (Heberer 2002;Luo et al 2014;Ternes et al 2015;Noguera-Oviedo and Aga 2016). Many of these pollutants are not removed in conventional wastewater treatment plants (WWTPs) and are therefore discharged into receiving waters (Eggen et al 2014;Tran et al 2018;Kümmerer et al 2019). Pharmaceuticals are bioactive substances that are designed to cause physiological effects in living organisms, and the risks of their adverse effects on ecosystems have increasingly been recognised (German Environment Agency 2016; Ternes 1998).…”
mentioning
confidence: 99%
“…Anthropogenic pollutants, which include pharmaceuticals such as lipid regulators, anticonvulsants and nonsteroidal antiinflammatory drugs, have been found in aquatic environments worldwide (Heberer 2002;Luo et al 2014;Ternes et al 2015;Noguera-Oviedo and Aga 2016). Many of these pollutants are not removed in conventional wastewater treatment plants (WWTPs) and are therefore discharged into receiving waters (Eggen et al 2014;Tran et al 2018;Kümmerer et al 2019). Pharmaceuticals are bioactive substances that are designed to cause physiological effects in living organisms, and the risks of their adverse effects on ecosystems have increasingly been recognised (German Environment Agency 2016; Ternes 1998).…”
mentioning
confidence: 99%
“…The most remarkable result was a highly positive effect (35% less toxic pressure, expressed as multi-substance potentially affected fraction, msPAF) of the phasing out of 26 substances of very high concern (SVHC) listed on the REACH Candidate List (out of the 1357 chemicals registered under REACH that were included in the 'future management' scenario). This clearly shows the high potential of focused regulatory measures to reduce the total chemical burden in general [31]. But specifically, the water quality change in relation to SVHC-focused emission reduction measures appeared to be more than proportional, driven by non-linear exposure-effect relationships (see also [32,33]).…”
Section: Exploring Future Optionsmentioning
confidence: 87%
“…The success of water quality protection and management regarding chemical pollution depends on the possibility to identify and implement optimal abatement techniques and management approaches [31,37]. The implementation of the solution-focused risk assessment paradigm into the practice of European water management is supported by a conceptual framework that guides the assessment process and provides a systematic overview of available abatement and management strategies.…”
Section: Further Developmentsmentioning
confidence: 99%
“…by incentivising or encouraging the production of sustainable, environmentally friendlier pharmaceuticals [39]. Research termed "green pharmacy" or "green toxicology" aims at developing novel production processes that follow a life-cycle approach and incorporate environmentally relevant properties, such as biodegradability, already when designing a new substance [15,38,40]. For instance, Rastogi et al [71] illustrate that it is also possible to redesign many existing pharmaceuticals and improve their environmental biodegradability through small molecular modifications.…”
Section: Theoretical Considerations On the Impact Of The Public Debatmentioning
confidence: 99%